Orchestra BioMed
OBIO
OBIO
65 hedge funds and large institutions have $98M invested in Orchestra BioMed in 2026 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 63 → 65 (+2)
1.03% more ownership
Funds ownership: 38.43% → 39.46% (+1%)
Holders
65
Holding in Top 10
–
Calls
$68K
Puts
$11K
Top Buyers
| 1 | +$3.82M | |
| 2 | +$1.95M | |
| 3 | +$934K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$209K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$194K |
Top Sellers
| 1 | -$1.51M | |
| 2 | -$725K | |
| 3 | -$503K | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$397K |
| 5 |
PA
Perceptive Advisors
New York
|
-$380K |
